Innovent (Phase 3 Study)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- May 29, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- The Phase 3 study has commenced with the first participant dosing completed.
- Company Description
- Innovent is a biopharmaceutical company focused on the development of innovative biologics for the treatment of various diseases, including autoimmune disorders like psoriasis.
- Market
- Pharmaceuticals
- Location
- China